Can Fite Biopharma Stock Market Value
| CANF Stock | USD 2.10 0.05 2.44% |
| Symbol | Can |
Can Fite Biopharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Can Fite. If investors know Can will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Can Fite listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Quarterly Revenue Growth (0.19) | Return On Assets (0.57) | Return On Equity (1.58) |
The market value of Can Fite Biopharma is measured differently than its book value, which is the value of Can that is recorded on the company's balance sheet. Investors also form their own opinion of Can Fite's value that differs from its market value or its book value, called intrinsic value, which is Can Fite's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Can Fite's market value can be influenced by many factors that don't directly affect Can Fite's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Can Fite's value and its price as these two are different measures arrived at by different means. Investors typically determine if Can Fite is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Can Fite's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Can Fite 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Can Fite's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Can Fite.
| 12/09/2022 |
| 11/28/2024 |
If you would invest 0.00 in Can Fite on December 9, 2022 and sell it all today you would earn a total of 0.00 from holding Can Fite Biopharma or generate 0.0% return on investment in Can Fite over 720 days. Can Fite is related to or competes with ImmuCell, Compugen, Evogene, Collplant Biotechnologies, Protalix Biotherapeutics, Corvus Pharmaceuticals, and Aldeyra. Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for th... More
Can Fite Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Can Fite's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Can Fite Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 21.59 | |||
| Value At Risk | (6.03) | |||
| Potential Upside | 7.65 |
Can Fite Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Can Fite's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Can Fite's standard deviation. In reality, there are many statistical measures that can use Can Fite historical prices to predict the future Can Fite's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.80) | |||
| Treynor Ratio | (0.21) |
Can Fite Biopharma Backtested Returns
Can Fite Biopharma secures Sharpe Ratio (or Efficiency) of -0.002, which signifies that the company had a -0.002% return per unit of risk over the last 3 months. Can Fite Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Can Fite's Standard Deviation of 4.02, mean deviation of 2.78, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.8, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Can Fite's returns are expected to increase less than the market. However, during the bear market, the loss of holding Can Fite is expected to be smaller as well. At this point, Can Fite Biopharma has a negative expected return of -0.008%. Please make sure to confirm Can Fite's maximum drawdown, daily balance of power, relative strength index, as well as the relationship between the skewness and day typical price , to decide if Can Fite Biopharma performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.1 |
Very weak reverse predictability
Can Fite Biopharma has very weak reverse predictability. Overlapping area represents the amount of predictability between Can Fite time series from 9th of December 2022 to 4th of December 2023 and 4th of December 2023 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Can Fite Biopharma price movement. The serial correlation of -0.1 indicates that less than 10.0% of current Can Fite price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.19 |
Can Fite Biopharma lagged returns against current returns
Autocorrelation, which is Can Fite stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Can Fite's stock expected returns. We can calculate the autocorrelation of Can Fite returns to help us make a trade decision. For example, suppose you find that Can Fite has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Can Fite regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Can Fite stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Can Fite stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Can Fite stock over time.
Current vs Lagged Prices |
| Timeline |
Can Fite Lagged Returns
When evaluating Can Fite's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Can Fite stock have on its future price. Can Fite autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Can Fite autocorrelation shows the relationship between Can Fite stock current value and its past values and can show if there is a momentum factor associated with investing in Can Fite Biopharma.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Can Fite Biopharma is a strong investment it is important to analyze Can Fite's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Can Fite's future performance. For an informed investment choice regarding Can Stock, refer to the following important reports:Check out Can Fite Correlation, Can Fite Volatility and Can Fite Alpha and Beta module to complement your research on Can Fite. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Can Fite technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.